Avatar for Finch Therapeutics

Using poop to cure disease

Using poop to cure disease

Finch is rapidly deploying its human-first discovery platform to a broad range of diseases linked to dysbiosis of the gut microbiome. We are systematically exploring the most promising diseases by generating and analyzing interventional data to empirically determine whether microbial interventions have a meaningful clinical impact. We are deploying our machine learning platform against these datasets to evaluate whether a Microbiotic based on a synthetic ecology is likely to be efficacious, or whether a whole-community microbiota therapy utilizing our Aquashell™ delivery technology is more promising. Finch currently has four active discovery programs aimed at addressing important unmet medical needs.

Gina Mendolia

Avatar for Gina Mendolia
Designer of Products, Data, & Services

Dean Liang Glettig

Avatar for Dean Liang Glettig
Director of Product Development at Finch Therapeutics